Evaluation of the Adequacy of the 2010 Revised World Health Organization Recommended Dosages of the First-line Antituberculosis Drugs for Children-Reference-Cited by-同舟云学术

Evaluation of the Adequacy of the 2010 Revised World Health Organization Recommended Dosages of the First-line Antituberculosis Drugs for Children

Published:2018-01 Issue:1 Volume:37 Page:43-51
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Yang Hongmei,Enimil Anthony,Gillani Fizza S.,Antwi Sampson,Dompreh Albert,Ortsin Antoinette,Adu Awhireng Eugene,Owusu Maxwell,Wiesner Lubbe,Peloquin Charles A.,Kwara Awewura

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health

Reference40 articles.

1. Requirements for the clinical evaluation of new anti-tuberculosis agents in children.;Donald;Int J Tuberc Lung Dis,2013

2. Antituberculosis drugs in children.;Schaaf;Clin Pharmacol Ther,2015

3. Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs.;Gumbo;Antimicrob Agents Chemother,2009

4. Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin.;Gumbo;Antimicrob Agents Chemother,2007

5. Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations.;Gumbo;Antimicrob Agents Chemother,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children;The International Journal of Tuberculosis and Lung Disease;2023-05-01

2. Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age;Antibiotics;2023-01-30

3. Pediatric Tuberculosis Management: A Global Challenge or Breakthrough?;Children;2022-07-27

4. Simultaneously Determining Seven Second-Line Anti-TB Drugs by UHPLC-MS: Application for TDM in HIV-TB Patients;Current Pharmaceutical Analysis;2021-11-23

5. Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study;Clinical Infectious Diseases;2021-10-19